News & Events CTI Announces Additions to the Business Development and Regulatory & Scientific Affairs Teams

CTI Announces Additions to the Business Development and Regulatory & Scientific Affairs Teams

February 4, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ February 4, 2020]

CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization is pleased to announce the additions of Savannah Doliboa and Nick Finan to the Business Development department and Rochelle Maher to the Regulatory & Scientific Affairs (RSA) department.

Savannah Doliboa
Director, Business Development & Client Management - North America
Nick Finan
Director, Business Development & Client Managment

Savannah Doliboa - Director, Business Development & Client Management - North America

Savannah joins CTI with many valuable years of working experience in the CRO industry. She previously held the position of Associate Director in Business Development at Pharm-Olam as well as business development and clinical operations roles at IQVIA and Medpace. In her new role at CTI, she will be overseeing part of our North American Business Development Sales Team. Savannah received her Bachelor's Degree in Biological Sciences from Wright State University.

"The addition of Savannah to our Business Development and Client Management team will allow for us to continue to expand our reach in the US," says Joseph McCafferty, Vice President, Global Business Development & Client Management. "We are very pleased to have her joining our North American BD Team and we are confident she will have a positive impact on our team and sales performance goals for 2020.
   
   

Nick Finan - Director, Business Development & Client Management, CRC

Nick comes to CTI with a strong background in sales and operations. Prior to joining the CTI team, Nick spent more than 8 years at Service First Logistics where he held various leadership roles such as Senior Broker and Corporate Sales Director. In his new role at CTI, he will be responsible for maintaining current vendor relations while also bringing in new business to our Clinical Research Center. Nick received his Bachelor's Degree in Economics with a Minor in Business Administration as well as his MBA at Thomas More College.

"We are excited to announce the addition of Nick to our business development department," remarks Joseph McCafferty. "He brings with him years of experience in leadership and sales that will be vital to our continued growth at the Clinical Research Center"

 

Rochelle Maher
Senior Director, Regulatory & Scientific Affairs

Rochelle Maher - Senior Director, Regulatory & Scientific Affairs

Rochelle joins CTI with more than 25 years within the industry and is a distinguished global drug development leader. Prior to joining CTI, Rochelle's most previous role was as Senior Director, Global Development Project Lead at Astellas. She has managed and provided strategic direction for teams spanning a variety of therapeutic areas, and she has an extensive background working with regulatory agencies around the world. Rochelle earned her Masters of Science in Biotechnology and a BS in Sociology from the University of Wisconsin.

"We are thrilled to have Rochelle join CTI," comments Dr. Scott Batty, Vice President, Global Regulatory & Scientific Affairs. "Her impressive background within the industry in addition to her experience working with the various regulatory agencies makes her an invaluable asset to our team."

Subscribe to our mailing list

* indicates required